Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-26-038518

Options or other derivatives

  • Director bought 247,830 shares at $0.81 ($99,999)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peters Richard Director 2026-03-31 Purchase · Pre-Funded Warrant +123,915 $0.81 $99,999 123,915 D: show line 1 in the form
Peters Richard Director 2026-03-31 Purchase · Common Warrant +123,915 123,915 D: show line 2 in the form
Loading xslF345X06/tm2610878-1_4seq1.xml…